Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 11,986 | 12,117 | 2,366 | 1,925 | 6,908 |
| Cost of Goods | 1,000 | 1,000 | 0 | N/A | 642 |
| Gross Profit | 10,986 | 11,117 | 2,366 | 1,925 | 6,266 |
| Operating Expenses | 5,153 | 4,157 | 5,580 | 3,138 | 4,315 |
| Operating Income | 5,833 | 6,960 | -3,214 | -1,213 | 2,593 |
| Interest Expense | 16 | 349 | 1,747 | 1,741 | 1,771 |
| Other Income | 386 | -16,907 | 105 | -89 | 37 |
| Pre-tax Income | 6,203 | -10,296 | -4,856 | -3,043 | 859 |
| Income Tax | 0 | 0 | N/A | -34 | N/A |
| Net Income Continuous | 6,203 | -10,296 | -4,856 | -3,009 | 859 |
| Net Income | $6,203 | $-10,296 | $-4,856 | $-3,009 | $859 |
| EPS Basic Total Ops | -0.40 | -2.49 | -0.82 | -0.68 | 0.21 |
| EPS Basic Continuous Ops | 0.21 | -0.54 | -0.83 | -0.68 | 0.22 |
| EPS Diluted Total Ops | -0.40 | -2.49 | -0.82 | -0.68 | 0.21 |
| EPS Diluted Continuous Ops | 0.21 | -0.54 | -0.83 | -0.68 | 0.22 |
| EBITDA(a) | $5,897 | $7,174 | $-2,566 | $-568 | $3,235 |